DE69232907D1 - Neue heterocyclische/cyclische amine - Google Patents

Neue heterocyclische/cyclische amine

Info

Publication number: DE69232907D1
Authority: DE; Germany
Prior art keywords: cyclic amines; new heterocyclic; compounds; formula; heterocyclic
Prior art date: 1991-03-28
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

DE69232907T

Other languages

English (en)

Other versions

DE69232907T2 (de

Inventor

Anabella Villalobos

Arthur Adam Nagel

Yuhpyng Liang Chen

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Eisai Co Ltd

Original Assignee

Eisai Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-03-28

Filing date

1992-03-09

Publication date

2003-02-27

1992-03-09 Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd

2003-02-27 Publication of DE69232907D1 publication Critical patent/DE69232907D1/de

2003-05-15 Application granted granted Critical

2003-05-15 Publication of DE69232907T2 publication Critical patent/DE69232907T2/de

2012-03-10 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurology (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Biomedical Technology (AREA)
General Health & Medical Sciences (AREA)
Neurosurgery (AREA)
Veterinary Medicine (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Plural Heterocyclic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Other In-Based Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Production Of Liquid Hydrocarbon Mixture For Refining Petroleum (AREA)
Thiazole And Isothizaole Compounds (AREA)

DE69232907T 1991-03-28 1992-03-09 Neue heterocyclische/cyclische amine Expired - Fee Related DE69232907T2 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US67691891A	1991-03-28	1991-03-28
PCT/US1992/001605 WO1992017475A1 (en)	1991-03-28	1992-03-09	Heterocyclic-cyclic amine derivatives

Publications (2)

Publication Number	Publication Date
DE69232907D1 true DE69232907D1 (de)	2003-02-27
DE69232907T2 DE69232907T2 (de)	2003-05-15

Family

ID=24716559

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE69232907T Expired - Fee Related DE69232907T2 (de)	1991-03-28	1992-03-09	Neue heterocyclische/cyclische amine

Country Status (29)

Country	Link
EP (1)	EP0646115B1 (de)
JP (3)	JP2659107B2 (de)
KR (1)	KR0179054B1 (de)
CN (1)	CN1044242C (de)
AT (1)	ATE231505T1 (de)
AU (2)	AU658194B2 (de)
BR (1)	BR9205811A (de)
CA (2)	CA2195129C (de)
CZ (1)	CZ289756B6 (de)
DE (1)	DE69232907T2 (de)
DK (1)	DK0646115T3 (de)
EG (1)	EG20281A (de)
ES (1)	ES2188584T3 (de)
FI (1)	FI934223L (de)
HU (1)	HU225047B1 (de)
IE (1)	IE920980A1 (de)
IL (3)	IL116122A0 (de)
MX (1)	MX9201419A (de)
MY (1)	MY108885A (de)
NO (1)	NO304071B1 (de)
NZ (3)	NZ242151A (de)
PL (3)	PL170567B1 (de)
PT (1)	PT100300B (de)
RU (1)	RU2119920C1 (de)
SG (1)	SG49055A1 (de)
UA (1)	UA45944C2 (de)
WO (1)	WO1992017475A1 (de)
YU (1)	YU31392A (de)
ZA (1)	ZA922239B (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5750542A (en) *	1993-09-28	1998-05-12	Pfizer	Benzisoxazole and benzisothizole derivatives as cholinesterase inhibitors
WO1993004063A1 (fr) *	1991-08-22	1993-03-04	Yoshitomi Pharmaceutical Industries, Ltd.	Compose de benzisoxazole et son utilisation
EP0535496A1 (de) *	1991-09-25	1993-04-07	Hoechst-Roussel Pharmaceuticals Incorporated	(1-Indanon-2-yl)Methylpiperidine, Zwischenprodukte und Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
EP0669920B1 (de) *	1992-11-23	2003-02-12	Aventis Pharmaceuticals Inc.	Substituierte 3-(aminoalkylamino)-1,2-benzisoxazole und verwandte verbindungen
US5494908A (en) *	1992-11-23	1996-02-27	Hoechst-Roussel Pharmaceutical Incorporated	Substituted 3-(aminoalkylamino)-1,2-benzisoxazoles and related compounds
GB9305623D0 (en) *	1993-03-18	1993-05-05	Merck Sharp & Dohme	Therapeutic agents
ATE260922T1 (de) *	1994-10-26	2004-03-15	Pfizer	Verfahren und zwischenprodukte zur herstellung von 5,7-dihydro-3-(2 1-benzylpiperidin-4-yl
US5912246A (en) *	1995-02-15	1999-06-15	Pharmacia & Upjohn Company	Imidazo 1,2-a!pyridines for the treatment of CNS and cardiac diseases
AU694626B2 (en) *	1995-03-22	1998-07-23	Nihon Nohyaku Co., Ltd.	Thiazole derivatives
JP3057763B2 (ja) *	1995-06-06	2000-07-04	ヘキスト・マリオン・ルセル・インコーポレイテツド	抗精神病薬としてのベンゾイソオキサゾール及びインダゾール誘導体
JPH09124643A (ja) *	1995-08-14	1997-05-13	Bristol Myers Squibb Co	抗うつ作用を有する１−アリールアルキル−４−（アルコキシピリジニル）−又は４−（アルコキシピリミジニル）ピペラジン誘導体
US5916902A (en) *	1995-09-13	1999-06-29	Pfizer Inc.	Processes and intermediates for preparing 5, 7-dihydro-3- 2-(1-benzylpiperidin-4-yl)ethyl-!6H-pyrrolo- 4, 5-F!-1, 2-benzisoxazol-6-one
AU7319096A (en) *	1995-11-02	1997-05-22	Merck Sharp & Dohme Limited	Bicyclic heteroaryl-alkylene-(homo)piperazinones and thione analogues thereof, their preparation and their use as selective agonists of 5-ht1-like receptors
FR2751412B3 (fr) *	1996-07-17	1998-09-25	Valbiofrance	Methodes de diagnostic in vitro de maladies neurodegeneratives et trousses pour la mise en oeuvre de ces methodes
US6013654A (en) *	1997-08-14	2000-01-11	Pharmacia & Upjohn Company	Imidazo[1,2-A]pyridines for the treatment of CNS and cardiac diseases
EP0976404A3 (de) *	1998-07-30	2001-06-27	Pfizer Products Inc.	Pharmazeutische Zubereitung zur Vorbeugung und Behandlung von kognitiven Störungen bei Säugetieren
CN1768745A (zh)	1998-09-30	2006-05-10	武田药品工业株式会社	改善膀胱排泄能力的药物
EP1050303A3 (de) *	1999-04-27	2003-01-15	Pfizer Products Inc.	Methoden und Zusammenstellungen zur Behandlung von altersgebundenen Verhaltensstörungen von Haustieren
US6951873B1 (en)	1999-04-27	2005-10-04	Pfizer Inc.	Methods for treating age-related behavioral disorders in companion animals
AU767726B2 (en) *	1999-04-30	2003-11-20	Pfizer Products Inc.	Radiotracers for in vivo study of acetylcholinesterase and Alzheimer's disease
GB9914486D0 (en)	1999-06-21	1999-08-18	Smithkline Beecham Plc	Medicaments
GB9917406D0 (en)	1999-07-23	1999-09-22	Smithkline Beecham Plc	Compounds
GB9917408D0 (en)	1999-07-23	1999-09-22	Smithkline Beecham Plc	Compounds
DE60034577T2 (de)	1999-09-01	2007-12-27	Eisai R&D Management Co., Ltd.	In 4-stellung substituierte piperidinderivate
EP1300395B1 (de)	2000-06-21	2009-09-02	Eisai R&D Management Co., Ltd.	4-substituierte piperidinverbindung
EP1436297B1 (de) *	2001-10-17	2007-04-25	Ciba Specialty Chemicals Holding Inc.	Photoaktivierbare stickstoffbasen
US7226915B2 (en) *	2003-05-15	2007-06-05	Hoffmann-La Roche Inc.	Diaminopyrroloquinazolines compounds as protein tyrosine phosphatase inhibitors
KR20060120694A (ko) *	2003-12-22	2006-11-27	메모리 파마슈티칼스 코포레이션	인돌, 1ｈ-인다졸, 1,2-벤즈이속사졸 및1,2-벤즈이소티아졸, 및 이들의 제법 및 용도
EP1609783A1 (de) *	2004-06-17	2005-12-28	Neuropharma S.A.U.	Marine verbindungen mit kalzium-kanal-blockierende eigenschaften zur behandlung der alzheimer-krankheit
DE102005038947A1 (de) *	2005-05-18	2006-11-30	Grünenthal GmbH	Substituierte Benzo[d]isoxazol-3-yl-amin-Verbindungen und deren Verwendung in Arzneimitteln
WO2007003961A2 (en) *	2005-06-30	2007-01-11	Prosidion Limited	Gpcr agonists
GB0519879D0 (en)	2005-09-30	2005-11-09	Astrazeneca Ab	Chemical process
JPWO2007126041A1 (ja)	2006-04-28	2009-09-10	エーザイ・アール・アンド・ディー・マネジメント株式会社	ベンゾイソオキサゾール化合物
US8580956B2 (en) *	2007-06-01	2013-11-12	Merck Sharp & Dohme Corp.	Gamma secretase modulators
EP2285783B1 (de)	2008-04-29	2014-05-21	Boehringer Ingelheim International GmbH	Indazolverbindungen als ccr1-rezeptorantagonisten
EP2297112B1 (de)	2008-05-06	2013-04-03	Boehringer Ingelheim International GmbH	Pyrazolverbindungen als ccr1-antagonisten
NZ591115A (en)	2008-09-26	2012-10-26	Boehringer Ingelheim Int	Azaindazole compounds as ccr1 receptor antagonists
MX2011005905A (es) *	2008-12-12	2011-06-20	Actelion Pharmaceuticals Ltd	Derivados de 5-amino-2-(1-hidroxi-etil)-tetrahidropirano.
IN2012DN03449A (de)	2009-10-21	2015-10-23	Boehringer Ingelheim Int
US8927550B2 (en)	2009-10-27	2015-01-06	Boehringer Ingelheim International Gmbh	Heterocyclic compounds as CCR1 receptor antagonists
CN102905532A (zh)	2010-02-09	2013-01-30	约翰斯.霍普金斯大学	用于改善认知功能的方法和组合物
EP2563787B1 (de)	2010-04-30	2014-11-26	Boehringer Ingelheim International GmbH	Azaindazolamidverbindungen als ccr1-rezeptor-antagonisten
JP5684406B2 (ja)	2010-12-23	2015-03-11	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	Ｃｃｒ１受容体アンタゴニストとしてのピラゾロピペリジン化合物
HK1215170A1 (zh)	2012-11-14	2016-08-19	The Johns Hopkins University	治療精神分裂症的方法和組合物
WO2014080633A1 (en) *	2012-11-21	2014-05-30	Raqualia Pharma Inc.	Polymorph forms
WO2014144663A1 (en)	2013-03-15	2014-09-18	The Johns Hopkins University	Methods and compositions for improving cognitive function
CA2904767C (en)	2013-03-15	2022-06-21	Agenebio, Inc.	Methods and compositions for improving cognitive function
EA034167B8 (ru)	2015-05-22	2021-04-27	Эйджинбайо, Инк.	Фармацевтические композиции леветирацетама пролонгированного высвобождения
RU2638155C1 (ru) *	2016-02-29	2017-12-12	Общество С Ограниченной Ответственностью "Сай Фарма"	Производные бензо[d]изоксазола и их применение
CN117597341A (zh) *	2021-08-10	2024-02-23	江苏恒瑞医药股份有限公司	磺酰胺衍生物、其制备方法及其在医药上的应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3488353A (en)	1967-05-29	1970-01-06	Sterling Drug Inc	New 1-((2-azaindolyl)-lower-alkyl) 4-substituted-piperazines
JPS51136666A (en) *	1975-05-19	1976-11-26	Dainippon Pharmaceut Co Ltd	Process for preparing 3-aminoalkyl-1,2-benzisoxazole derivatives.
US4396770A (en) *	1982-04-09	1983-08-02	Hoechst-Roussel Pharmaceuticals Inc.	1-[3-(6-Fluoro-1,2-benzisoxazol-3-yl)propyl]-4-hydroxy-4-phenylpiperidines
IL66866A (en) *	1982-04-09	1987-08-31	Hoechst Roussel Pharma	1-(3-(6-fluoro-1,2-benzisoxazol-3-yl)propyl)-4-(substituted)-piperazines and-piperidines,a process for the preparation thereof,and pharmaceutical compositions containing them
US4489075A (en) *	1982-05-15	1984-12-18	Pfizer Inc.	Cyclic sulfonamidoalkyl substituted 4-piperidinoquinazoline cardiac stimulants
PH22302A (en) *	1985-02-11	1988-07-22	Fujisawa Pharmaceutical Co	Piperidine compounds
DK623586A (da) *	1985-12-27	1987-06-28	Eisai Co Ltd	Piperidinderivater eller salte deraf og farmaceutiske kompositioner indeholdende forbindelserne
JPS63234065A (ja) *	1987-03-23	1988-09-29	Mitsubishi Rayon Co Ltd	包接能を有する高分子組成物
JPH0657707B2 (ja) *	1987-05-25	1994-08-03	吉富製薬株式会社	ピペリジン化合物
FI95572C (fi) *	1987-06-22	1996-02-26	Eisai Co Ltd	Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi
US4980365A (en) *	1987-07-13	1990-12-25	Hoechst-Roussel Pharmaceuticals Inc.	N-substituted-5,6-dimethoxy-1,2-benzisoxazole-3-propanamine and related compounds as analgesic and hypotensive agents
ATE87918T1 (de) *	1988-02-19	1993-04-15	Lilly Co Eli	Tetrazolverbindungen als antagonisten der excitatorischen aminosaeurerezeptoren.
JPH0283375A (ja) *	1988-09-21	1990-03-23	Dainippon Pharmaceut Co Ltd	２−置換ピペラジニル−２−（１，２−ベンズイソキサゾール−３−イル）酢酸誘導体
FR2654104B1 (fr) *	1989-11-07	1992-01-03	Adir	Nouveaux derives du 1,2-benzisoxazole, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
CA2105666C (en) *	1991-04-17	2006-02-14	Kjell Anders Ivan Svensson	New centrally acting substituted phenylazacycloalkanes

1992
- 1992-03-09 UA UA93004393A patent/UA45944C2/uk unknown
- 1992-03-09 FI FI934223A patent/FI934223L/fi not_active Application Discontinuation
- 1992-03-09 CA CA002195129A patent/CA2195129C/en not_active Expired - Fee Related
- 1992-03-09 PL PL92300711A patent/PL170567B1/pl not_active IP Right Cessation
- 1992-03-09 CA CA002107105A patent/CA2107105C/en not_active Expired - Fee Related
- 1992-03-09 SG SG1996005572A patent/SG49055A1/en unknown
- 1992-03-09 ES ES92921695T patent/ES2188584T3/es not_active Expired - Lifetime
- 1992-03-09 AU AU18782/92A patent/AU658194B2/en not_active Ceased
- 1992-03-09 PL PL92313811A patent/PL171915B1/pl not_active IP Right Cessation
- 1992-03-09 JP JP4510182A patent/JP2659107B2/ja not_active Expired - Fee Related
- 1992-03-09 DK DK92921695T patent/DK0646115T3/da active
- 1992-03-09 BR BR9205811A patent/BR9205811A/pt not_active Application Discontinuation
- 1992-03-09 RU RU93055137A patent/RU2119920C1/ru not_active IP Right Cessation
- 1992-03-09 WO PCT/US1992/001605 patent/WO1992017475A1/en not_active Ceased
- 1992-03-09 PL PL92313812A patent/PL171914B1/pl not_active IP Right Cessation
- 1992-03-09 DE DE69232907T patent/DE69232907T2/de not_active Expired - Fee Related
- 1992-03-09 AT AT92921695T patent/ATE231505T1/de not_active IP Right Cessation
- 1992-03-09 HU HU9302733A patent/HU225047B1/hu not_active IP Right Cessation
- 1992-03-09 EP EP92921695A patent/EP0646115B1/de not_active Expired - Lifetime
- 1992-03-09 CZ CS19923958A patent/CZ289756B6/cs not_active IP Right Cessation
- 1992-03-22 IL IL11612295A patent/IL116122A0/xx unknown
- 1992-03-22 IL IL101327A patent/IL101327A/en active IP Right Grant
- 1992-03-22 IL IL11612292A patent/IL116122A/en active IP Right Grant
- 1992-03-26 PT PT100300A patent/PT100300B/pt not_active IP Right Cessation
- 1992-03-26 EG EG15592A patent/EG20281A/xx active
- 1992-03-27 CN CN92102178A patent/CN1044242C/zh not_active Expired - Fee Related
- 1992-03-27 NZ NZ242151A patent/NZ242151A/en not_active IP Right Cessation
- 1992-03-27 IE IE098092A patent/IE920980A1/en not_active IP Right Cessation
- 1992-03-27 MY MYPI92000531A patent/MY108885A/en unknown
- 1992-03-27 YU YU31392A patent/YU31392A/sh unknown
- 1992-03-27 ZA ZA922239A patent/ZA922239B/xx unknown
- 1992-03-27 NZ NZ250987A patent/NZ250987A/en not_active IP Right Cessation
- 1992-03-27 NZ NZ248946A patent/NZ248946A/en not_active IP Right Cessation
- 1992-03-30 MX MX9201419A patent/MX9201419A/es not_active IP Right Cessation
1993
- 1993-09-27 KR KR1019930702929A patent/KR0179054B1/ko not_active Expired - Fee Related
- 1993-09-27 NO NO933445A patent/NO304071B1/no unknown
1995
- 1995-06-20 AU AU21788/95A patent/AU674477B2/en not_active Ceased
1997
- 1997-03-06 JP JP9052097A patent/JP3051076B2/ja not_active Expired - Fee Related
1999
- 1999-12-24 JP JP11368302A patent/JP2000154185A/ja active Pending

Also Published As

Publication number	Publication date
ES2188584T3 (es)	2003-07-01
IL101327A0 (en)	1992-11-15
SG49055A1 (en)	1998-05-18
WO1992017475A1 (en)	1992-10-15
JP2000154185A (ja)	2000-06-06
NZ248946A (en)	1995-04-27
NO933445D0 (no)	1993-09-27
HU225047B1 (en)	2006-05-29
JP3051076B2 (ja)	2000-06-12
BR9205811A (pt)	1994-06-28
FI934223A7 (fi)	1993-09-27
PT100300B (pt)	1999-09-30
HUT68357A (en)	1995-06-28
RU2119920C1 (ru)	1998-10-10
IL116122A0 (en)	1996-01-31
PL171914B1 (pl)	1997-06-30
EG20281A (en)	1998-07-30
PL171915B1 (pl)	1997-06-30
IL101327A (en)	1998-06-15
FI934223A0 (fi)	1993-09-27
AU2178895A (en)	1995-09-07
DE69232907T2 (de)	2003-05-15
HU9302733D0 (en)	1993-12-28
KR0179054B1 (en)	1999-03-20
NZ250987A (en)	1997-06-24
ATE231505T1 (de)	2003-02-15
CA2107105C (en)	2003-10-07
CN1044242C (zh)	1999-07-21
IL116122A (en)	1998-10-30
PT100300A (pt)	1993-08-31
PL170567B1 (pl)	1997-01-31
EP0646115B1 (de)	2003-01-22
YU31392A (sh)	1994-12-28
CZ289756B6 (cs)	2002-04-17
MY108885A (en)	1996-11-30
NO933445L (no)	1993-09-27
NZ242151A (en)	1994-10-26
DK0646115T3 (da)	2003-04-22
NO304071B1 (no)	1998-10-19
CZ395892A3 (en)	1994-04-13
CA2107105A1 (en)	1992-09-29
AU674477B2 (en)	1996-12-19
CN1065267A (zh)	1992-10-14
JPH10158264A (ja)	1998-06-16
FI934223L (fi)	1993-09-27
EP0646115A1 (de)	1995-04-05
MX9201419A (es)	1992-10-01
AU1878292A (en)	1992-11-02
ZA922239B (en)	1993-09-27
CA2195129A1 (en)	1992-09-29
CA2195129C (en)	2002-09-10
UA45944C2 (uk)	2002-05-15
IE920980A1 (en)	1992-10-07
AU658194B2 (en)	1995-04-06
JPH06500794A (ja)	1994-01-27
JP2659107B2 (ja)	1997-09-30

Publication	Publication Date	Title
DE69232907D1 (de)	2003-02-27	Neue heterocyclische/cyclische amine
NO892894D0 (no)	1989-07-13	Nye kondenserte heterocykliske forbindelser.
LU93229I2 (fr)	2016-11-21	"pitolisant et ses sels pharmaceutiquement acceptables, tel que chlorhydrate"
ES2111639T3 (es)	1998-03-16	Derivados de 3-aminopiperidina y heterociclos relacionados que contienen nitrogeno.
DK0468470T3 (da)	1997-09-22	Benzimidazoler, lægemidler indeholdende sådanne forbindelser og fremgangsmåde til deres fremstilling
NO931694D0 (no)	1993-05-10	Nye 4-arylpiperaciner og 4-arylpiperidiner
TR199800011T1 (xx)	1998-04-21	Benzo$g] kuinolin t�revleri
NO924598D0 (no)	1992-11-27	Fremstilling av substituerte piperidiner
DK163287A (da)	1987-10-02	1,4-diazepiner og farmaceutiske midler med indhold af saadanne forbindelser
DK0450420T3 (da)	1995-02-20	Heterocyclisk substituerede dihydropyridiner, fremgangsmåde til deres fremstilling og deres anvendelse i lægemidler
DK671588D0 (da)	1988-12-01	Bisphenylalkylpiperazinderivater og fremgangsmaade til fremstilling deraf
NO930205D0 (no)	1993-01-21	Benzimidazoler, legemidler inneholdende disse, og fremgangsmaate for deres fremstilling
ATE283269T1 (de)	2004-12-15	5-(heteroaryl)alkyl)-3-oxo-pyrido(1,2- a)benzimidazol-4-carboxamid (pbi) derivate zur behandlung von störungen des zentralen nervensystems
DK1105388T3 (da)	2003-08-18	N-substituerede azabicycloheptan-derivater, fremstilling og anvendelse heraf
FI972528A0 (fi)	1997-06-13	Menetelmä N-(4-(5-(syklopentyylioksikarbonyyli)amino-1-metyyli-indol-3-yyli-metyyli)-3-metoksibentsoyyli)-2-metyylibentseenisulfonamidin fysikaalisen muodon valmistamiseksi

Legal Events

Date	Code	Title	Description
2004-02-19	8364	No opposition during term of opposition
2010-01-21	8339	Ceased/non-payment of the annual fee